Market Tracker

08/16 11:26am ET

Meridian Bioscience Inc (NASDAQ:VIVO)

13.88
Delayed Data
As of 11:10am ET
 +0.075 / +0.54%
Today’s Change
10.75
Today|||52-Week Range
19.85
-21.61%
Year-to-Date

Today’s Trading

Previous close13.80
Today’s open13.85
Day’s range13.80 - 14.03
Volume38,415
Average volume (3 months)293,504
Market cap$582.4M
Dividend yield3.60%
Data as of 11:10am ET, 08/16/2017

Growth & Valuation

Earnings growth (last year)-10.59%
Earnings growth (this year)-16.25%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+0.64%
P/E ratio27.8
Price/Sales4.17
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
LNTHLantheus Holdings In...-0.23-1.34%
CALACalithera Bioscience...-0.35-2.44%
ALRPRBAlere Inc+1.59+0.41%
OXFDOxford Immunotec Glo...+0.17+1.06%
Data as of 11:22am ET, 08/16/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$196.1M
Annual profit (last year)$32.2M
Net profit margin16.44%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John A. Kraeutler
President &
Chief Commercial Officer
Richard L. Eberly
Corporate headquarters
Cincinnati, Ohio

Forecasts